+41.1%
GSK vs CPAY
+88.4%
-47.2%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | CPAY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -1.0% | +0.9% | 0.0% |
| 7D | -5.3% | -7.0% | +1.7% | -4.4% |
| 30D | -3.7% | +5.5% | -9.1% | -4.4% |
| 3M | -7.3% | +4.3% | -11.6% | -7.9% |
| 6M | -4.2% | +22.6% | -26.9% | -7.1% |
| YTD | +0.9% | +42.8% | -42.0% | -4.7% |
| 1Y | +7.3% | +55.0% | -47.7% | +0.3% |
| 3Y | +52.7% | +82.7% | -29.9% | +36.6% |
| All | +41.1% | +88.4% | -47.2% | +23.4% |
Cumulative growth
Daily Returns
Daily percentage return beside CPAY.
Daily Out/Under-Performance
Portfolio return minus CPAY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CPAY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded CPAY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling